Urinastatin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

3 API Suppliers, 1 EU WC, 1 KDMF, 2 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

1 Dossiers, 1 Listed Dossiers

MARKET PLACE

7 APIs, 3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 JP Standards

1 JP Standards

DIGITAL CONTENT

1 News

1 News

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: 80499-32-7, 80449-32-7, 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-8-ene, Trypsin inhibitor (human urine urinastatin protein moiety), 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene, 2,4-dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-

Molecular Formula

C₁₃H₁₆O₃

Molecular Weight

220.26 g/mol

InChI Key

ODVKSTFPQDVPJZ-UHFFFAOYSA-N

1 2D Structure

Urinastatin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene

2.1.2 InChI

InChI=1S/C13H16O3/c1-2-6-13(7-3-1)9-15-12(16-10-13)11-5-4-8-14-11/h1-2,4-5,8,12H,3,6-7,9-10H2

2.1.3 InChI Key

ODVKSTFPQDVPJZ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CC2(CC=C1)COC(OC2)C3=CC=CO3

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Acid-stable Protease Inhibitor

2. Miraclid

3. Mr 20

4. Mr 20 (magnetic Powder) Of Urinastatin

5. Mr-20 (magnetic Powder)

6. Trypsin Inhibitor Mr-20

7. Ulinastatin

8. Urinary Trypsin Inhibitor

9. Urinary Trypsin Inhibitor (68)

10. Urinary Trypsin Inhibitor-like Inhibitor (43)

11. Urinastatin

12. Uti(68)

13. Uti68

2.2.2 Depositor-Supplied Synonyms

1. 80499-32-7

2. 80449-32-7

3. 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-8-ene

4. Trypsin Inhibitor (human Urine Urinastatin Protein Moiety)

5. 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene

6. 2,4-dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-

7. Trypsin Inhibitor Mr-20

8. Mr-20 (magnetic Powder)

9. Uti(68)

10. Acid-stable Protease Inhibitor

11. Urinary Trypsin Inhibitor (68)

12. Mr 20

13. Unii-or3s9if86u

14. Uristatin

15. Mingin

16. Urinary Trypsin Inhibitor-like Inhibitor (43)

17. Trypsin Inhibitor Uti

18. Ulinastatin [inn:jan]

19. Trypsin Inhibitor, Mingin

20. Trypsin Inhibitor, Bikunin

21. Urinary Trypsin Inhibitor 1

22. 3-(2-furanyl)-2,4-dioxaspiro(5.5)undec-8-ene

23. Dtxsid801001247

24. Bcp08067

25. Akos025401879

26. Ac-26827

27. Hy-21646

28. D77201

29. 9-(2-furyl)-8,10-dioxaspiro[5.5]undec-3-ene

2.3 Create Date

2005-08-01

3 Chemical and Physical Properties

Molecular Formula	C₁₃H₁₆O₃
Molecular Weight	220.26 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	1
Exact Mass	220.109944368 g/mol
Monoisotopic Mass	220.109944368 g/mol
Topological Polar Surface Area	31.6 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	266
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Trypsin Inhibitors

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)